I can't directly create a PowerPoint file, but I can provide you with a complete slide-by-slide outline with content that you can easily copy into PowerPoint. I'll also include speaker notes and suggest visuals for each slide.

---

# Pharma Data Exchange Hub
## AWS Strategy Presentation for Merck

---

## Slide 1: Title Slide

**Title:** Pharma Data Exchange Hub

**Subtitle:** Accelerating CMO Data Integration from Months to Days

**Presented by:** [Your Name], AWS Solutions Architect

**Date:** [Date]

**Logo placement:** AWS logo, Merck logo (if permitted)

*Speaker Notes:*
Welcome everyone. Today we'll present our strategic approach to solving Merck's CMO data exchange challenge. Our goal is to reduce data access timelines from months to days using a standardized, pattern-based approach built on AWS services.

---

## Slide 2: Agenda

```
1. Understanding the Challenge
2. Root Cause Analysis
3. Strategic Approach
4. Architecture Patterns (4 Options)
5. Unified Control Plane
6. Security & Compliance
7. Implementation Roadmap
8. Success Metrics
9. Next Steps
```

*Speaker Notes:*
Here's our agenda for today. We'll start by framing the problem, then walk through our proposed solution architecture, and finish with a clear implementation path.

---

## Slide 3: The Business Challenge

**Title:** Current State: The Data Access Bottleneck

**Content:**

| Challenge | Impact |
|-----------|--------|
| 3-6 month integration timelines | Delayed insights, slower decision-making |
| Custom integration for each CMO | High cost, non-scalable |
| Lengthy legal negotiations | Blocks technical progress |
| Varied CMO technical maturity | No one-size-fits-all solution |

**Key Message Box:**
> "The constraint is **time-to-access**, not technical feasibility"

*Visual suggestion:* Timeline graphic showing current 3-6 month process

*Speaker Notes:*
Let's be clear about the problem we're solving. Merck can integrate with CMOs—the technology exists. The issue is that each integration takes 3-6 months due to legal negotiations, custom technical work, and coordination overhead. This delays critical manufacturing insights and creates operational inefficiencies.

---

## Slide 4: Root Cause Analysis

**Title:** Why Does It Take So Long?

**Visual:** Three pillars with time estimates

```
┌─────────────────┐  ┌─────────────────┐  ┌─────────────────┐
│                 │  │                 │  │                 │
│     LEGAL       │  │   TECHNICAL     │  │     TRUST       │
│                 │  │                 │  │                 │
│  • DPA creation │  │  • Discovery    │  │  • Data custody │
│  • Security     │  │  • Custom build │  │    concerns     │
│    review       │  │  • Testing      │  │  • IP protection│
│  • Liability    │  │  • Deployment   │  │  • Audit rights │
│                 │  │                 │  │                 │
│   4-8 weeks     │    4-8 weeks      │  │   Ongoing       │
└─────────────────┘  └─────────────────┘  └─────────────────┘
                           │
                           ▼
                    SEQUENTIAL PROCESS
                      = 3-6 MONTHS
```

*Speaker Notes:*
When we analyzed the delays, we found three root causes. First, legal negotiations—every CMO requires custom data processing agreements. Second, technical integration—each CMO has different systems, requiring custom development. Third, trust—CMOs are concerned about data custody and IP protection. These happen sequentially, compounding the delays.

---

## Slide 5: Our Strategic Approach

**Title:** The Solution: Parallelize and Pre-Solve

**Visual:** Before/After comparison

**BEFORE (Sequential):**
```
Legal → Technical Discovery → Custom Build → Test → Production
                        = 3-6 Months
```

**AFTER (Parallel + Pre-Solved):**
```
┌─────────────────────────────────────────────┐
│  Pre-negotiated    +    Standardized    +   │
│  Legal Templates        Patterns            │
│         │                    │              │
│         └────────┬───────────┘              │
│                  ▼                          │
│         Self-Service Onboarding             │
│                  │                          │
│                  ▼                          │
│            = 1-4 Weeks                      │
└─────────────────────────────────────────────┘
```

*Speaker Notes:*
Our approach attacks all three root causes simultaneously. We pre-negotiate legal templates that CMOs can accept quickly. We create standardized integration patterns so there's no custom development. And we build trust infrastructure—like AWS Clean Rooms—that addresses data custody concerns by design. This transforms a sequential 6-month process into a parallel 1-4 week process.

---

## Slide 6: Solution Overview

**Title:** Pharma Data Exchange Hub - Conceptual Architecture

**Visual:** High-level architecture diagram

```
┌─────────────────────────────────────────────────────────────┐
│                    CMO ECOSYSTEM                             │
│   ┌─────────┐  ┌─────────┐  ┌─────────┐  ┌─────────┐       │
│   │ CMO A   │  │ CMO B   │  │ CMO C   │  │ CMO D   │       │
│   │(Cloud)  │  │(Snowflk)│  │(On-Prem)│  │(Legacy) │       │
│   └────┬────┘  └────┬────┘  └────┬────┘  └────┬────┘       │
└────────┼────────────┼────────────┼────────────┼─────────────┘
         │            │            │            │
         ▼            ▼            ▼            ▼
┌─────────────────────────────────────────────────────────────┐
│              PATTERN LIBRARY (Choose Your Path)             │
│   ┌─────────┐  ┌─────────┐  ┌─────────┐  ┌─────────┐       │
│   │ Data    │  │ Clean   │  │Snowflake│  │ Secure  │       │
│   │Exchange │  │ Rooms   │  │ Connect │  │Transfer │       │
│   └─────────┘  └─────────┘  └─────────┘  └─────────┘       │
└─────────────────────────────────────────────────────────────┘
                          │
                          ▼
┌─────────────────────────────────────────────────────────────┐
│                 MERCK DATA PLATFORM                          │
│        ┌─────────────────────────────────────┐              │
│        │   Unified Data Lake + Governance    │              │
│        └─────────────────────────────────────┘              │
└─────────────────────────────────────────────────────────────┘
```

**Three Key Components:**
1. **Pattern Library** - Multiple integration options for CMO flexibility
2. **Self-Service Portal** - CMO onboarding without Merck IT bottleneck
3. **Unified Governance** - Consistent security, quality, and compliance

*Speaker Notes:*
Here's the conceptual architecture. At the top, we have CMOs with varying technical capabilities. In the middle, we offer a pattern library—four standardized ways to connect. CMOs choose the pattern that fits their infrastructure. At the bottom, all data flows into Merck's unified data platform with consistent governance. This design accommodates CMO diversity while giving Merck standardization.

---

## Slide 7: Pattern Overview

**Title:** Four Integration Patterns - Meeting CMOs Where They Are

**Visual:** 2x2 matrix

```
                    CMO Cloud Maturity
                    Low ◄─────────► High
                ┌───────────────┬───────────────┐
        High    │   Pattern 4   │   Pattern 1   │
                │   Secure      │   AWS Data    │
    Data        │   Transfer    │   Exchange    │
    Volume      │   (SFTP)      │   (Publish)   │
                ├───────────────┼───────────────┤
        Low     │   Pattern 4   │   Pattern 2   │
                │   Secure      │   AWS Clean   │
                │   Transfer    │   Rooms       │
                │   (SFTP)      │   (Collab)    │
                └───────────────┴───────────────┘
                
        + Pattern 3: Snowflake Integration (Cross-cutting)
```

| Pattern | Best For | Time to Value |
|---------|----------|---------------|
| 1. AWS Data Exchange | Cloud-native CMOs willing to publish | 1-2 weeks |
| 2. AWS Clean Rooms | Privacy-sensitive collaborations | 2-3 weeks |
| 3. Snowflake Integration | CMOs already on Snowflake | 1-2 weeks |
| 4. Secure File Transfer | Legacy/on-prem CMOs | 2-4 weeks |

*Speaker Notes:*
We've designed four patterns to accommodate different CMO situations. Pattern 1 is for cloud-savvy CMOs who can publish data to AWS Data Exchange. Pattern 2 uses Clean Rooms for CMOs concerned about data leaving their control. Pattern 3 leverages Snowflake's native sharing for CMOs already on that platform. Pattern 4 is our fallback for legacy environments—managed SFTP. The key insight: CMOs choose their comfort level, but Merck gets consistent, governed data regardless.

---

## Slide 8: Pattern 1 - AWS Data Exchange

**Title:** Pattern 1: AWS Data Exchange (Publisher/Subscriber)

**Visual:** Architecture diagram

```
┌──────────────────┐         ┌──────────────────┐
│   CMO Account    │         │  Merck Account   │
│  ┌────────────┐  │         │  ┌────────────┐  │
│  │ Mfg Data   │  │         │  │ S3 Landing │  │
│  └─────┬──────┘  │         │  │ Zone       │  │
│        │         │         │  └─────▲──────┘  │
│        ▼         │         │        │         │
│  ┌────────────┐  │  AWS    │        │         │
│  │ Publish to │  │  Data   │  ┌─────┴──────┐  │
│  │ Data Exch  │──┼─Exchange┼─▶│ Subscribe  │  │
│  │ (Private)  │  │         │  │ (Entitled) │  │
│  └────────────┘  │         │  └────────────┘  │
└──────────────────┘         └──────────────────┘
```

**Key Benefits:**
- ✅ Managed data marketplace - no infrastructure to build
- ✅ Private offers - data only visible to Merck
- ✅ Automatic updates - subscribe once, receive continuously
- ✅ Built-in entitlements and access control

**AWS Services:** AWS Data Exchange, S3, Glue, Lake Formation

*Speaker Notes:*
Pattern 1 uses AWS Data Exchange, which is essentially a managed data marketplace. CMOs publish datasets as private offers visible only to Merck. Merck subscribes and automatically receives updates. This is ideal for CMOs already comfortable with cloud and willing to push data. The advantage is minimal infrastructure—AWS manages the exchange mechanics.

---

## Slide 9: Pattern 2 - AWS Clean Rooms

**Title:** Pattern 2: AWS Clean Rooms (Privacy-Preserving Collaboration)

**Visual:** Architecture diagram

```
┌──────────────────┐         ┌──────────────────┐
│   CMO Account    │         │  Merck Account   │
│  ┌────────────┐  │         │  ┌────────────┐  │
│  │ Mfg Data   │  │         │  │ Quality    │  │
│  │ (Stays     │  │         │  │ Data       │  │
│  │  Here!)    │  │         │  └─────┬──────┘  │
│  └─────┬──────┘  │         │        │         │
│        │         │         │        │         │
│        ▼         │         │        ▼         │
│  ┌────────────┐  │         │  ┌────────────┐  │
│  │ Configured │◀─┼─────────┼─▶│ Configured │  │
│  │ Table      │  │  CLEAN  │  │ Table      │  │
│  └────────────┘  │  ROOM   │  └────────────┘  │
└──────────────────┘    │    └──────────────────┘
                        ▼
               ┌─────────────────┐
               │ Aggregated      │
               │ Results Only    │
               │ (No Raw Data)   │
               └─────────────────┘
```

**Key Benefits:**
- ✅ Data never leaves CMO's account
- ✅ Only approved queries can run
- ✅ Results are aggregated - no row-level exposure
- ✅ Addresses IP and custody concerns

**AWS Services:** AWS Clean Rooms, S3, Glue Data Catalog

*Speaker Notes:*
Pattern 2 is our answer to the trust problem. With Clean Rooms, CMO data never leaves their AWS account. Instead, both parties configure tables in a shared collaboration. Only pre-approved queries can run, and results are aggregated—no raw data exposed. This is powerful for CMOs who say "we can't let our data leave our control." With Clean Rooms, it doesn't have to.

---

## Slide 10: Pattern 3 - Snowflake Integration

**Title:** Pattern 3: Snowflake Integration (Platform Accommodation)

**Visual:** Architecture diagram

```
┌──────────────────┐         ┌──────────────────┐
│  CMO Snowflake   │         │  Merck AWS       │
│  ┌────────────┐  │         │  ┌────────────┐  │
│  │ Mfg Data   │  │         │  │ Option A:  │  │
│  │ Tables     │  │         │  │ Snowflake  │  │
│  └─────┬──────┘  │         │  │ Reader Acct│  │
│        │         │         │  └────────────┘  │
│        ▼         │         │        OR        │
│  ┌────────────┐  │ Secure  │  ┌────────────┐  │
│  │ Snowflake  │  │ Share   │  │ Option B:  │  │
│  │ Secure     │──┼─────────┼─▶│ S3 External│  │
│  │ Data Share │  │   or    │  │ Stage +    │  │
│  └────────────┘  │ S3 Stage│  │ Glue       │  │
│                  │         │  └────────────┘  │
└──────────────────┘         └──────────────────┘
```

**Key Benefits:**
- ✅ Leverages CMO's existing Snowflake investment
- ✅ Native Snowflake sharing - zero copy, instant access
- ✅ Alternative S3 stage for AWS-native consumption
- ✅ Minimal CMO effort - they already know Snowflake

**AWS Services:** S3, Glue (Snowflake connector), PrivateLink

*Speaker Notes:*
Many CMOs have already invested in Snowflake. Pattern 3 meets them where they are. CMOs can use Snowflake's native secure data sharing to give Merck access—either through a Snowflake reader account or by staging to S3 for AWS-native consumption. This pattern has the fastest time-to-value for Snowflake CMOs because we're leveraging capabilities they already have.

---

## Slide 11: Pattern 4 - Secure File Transfer

**Title:** Pattern 4: Secure File Transfer (Legacy/On-Prem CMOs)

**Visual:** Architecture diagram

```
┌──────────────────┐         ┌──────────────────────────────┐
│  CMO On-Premises │         │       Merck AWS Account      │
│  ┌────────────┐  │         │  ┌─────────────────────────┐ │
│  │ MES/ERP    │  │         │  │  AWS Transfer Family    │ │
│  │ System     │  │  SFTP   │  │  ┌─────────────────┐    │ │
│  └─────┬──────┘  │  over   │  │  │ Managed SFTP    │    │ │
│        │         │  VPN    │  │  │ Endpoint        │    │ │
│        ▼         │         │  │  └────────┬────────┘    │ │
│  ┌────────────┐  │         │  └───────────┼─────────────┘ │
│  │ Export     │──┼─────────┼──────────────┘               │
│  │ CSV/Parquet│  │         │              │               │
│  └────────────┘  │         │              ▼               │
└──────────────────┘         │  ┌─────────────────────────┐ │
                             │  │ S3 → EventBridge →      │ │
        ┌────────────┐       │  │ Step Functions →        │ │
        │ Direct     │       │  │ Glue (Transform)        │ │
        │ Connect/VPN│───────│  └─────────────────────────┘ │
        └────────────┘       └──────────────────────────────┘
```

**Key Benefits:**
- ✅ Works with any CMO - no cloud required
- ✅ Familiar protocol (SFTP) - minimal CMO training
- ✅ Managed service - no servers to maintain
- ✅ Event-driven processing - automatic on file arrival

**AWS Services:** Transfer Family, Direct Connect/VPN, S3, EventBridge, Step Functions, Glue

*Speaker Notes:*
Pattern 4 is our universal fallback. Some CMOs have limited cloud maturity or regulatory constraints that prevent cloud adoption. For them, we offer managed SFTP through AWS Transfer Family. CMOs export files from their MES or ERP systems and upload via SFTP over a secure VPN connection. On the AWS side, file arrival triggers automated processing. This pattern has the widest applicability but slightly longer setup time due to network configuration.

---

## Slide 12: Pattern Selection Guide

**Title:** Choosing the Right Pattern

**Visual:** Decision tree

```
                    ┌─────────────────────┐
                    │ Does CMO have AWS   │
                    │ account?            │
                    └──────────┬──────────┘
                               │
              ┌────────────────┴────────────────┐
              │ YES                             │ NO
              ▼                                 ▼
    ┌─────────────────────┐          ┌─────────────────────┐
    │ Data custody        │          │ Does CMO use        │
    │ concerns?           │          │ Snowflake?          │
    └──────────┬──────────┘          └──────────┬──────────┘
               │                                │
    ┌──────────┴──────────┐          ┌──────────┴──────────┐
    │ YES            NO   │          │ YES            NO   │
    ▼                ▼    │          ▼                ▼
┌────────┐    ┌────────┐  │    ┌────────┐      ┌────────┐
│Pattern │    │Pattern │  │    │Pattern │      │Pattern │
│   2    │    │   1    │  │    │   3    │      │   4    │
│ Clean  │    │ Data   │  │    │Snowflk │      │ SFTP   │
│ Rooms  │    │Exchange│  │    │        │      │        │
└────────┘    └────────┘  │    └────────┘      └────────┘
```

**Pattern Summary:**

| Pattern | CMO Requirement | Merck Benefit | Time |
|---------|-----------------|---------------|------|
| 1 - Data Exchange | AWS account, publish capability | Automated updates | 1-2 wks |
| 2 - Clean Rooms | AWS account, privacy needs | Collaboration without data movement | 2-3 wks |
| 3 - Snowflake | Snowflake platform | Leverage existing investment | 1-2 wks |
| 4 - Transfer | Basic IT (SFTP) | Universal compatibility | 2-4 wks |

*Speaker Notes:*
This decision tree helps select the right pattern for each CMO. We start by asking if they have an AWS account. If yes, we check for data custody concerns—Clean Rooms if yes, Data Exchange if no. If they don't have AWS, we check for Snowflake. If neither, we default to secure file transfer. The key point: every CMO has a path, and Merck doesn't have to build custom integrations.

---

## Slide 13: Unified Control Plane

**Title:** Pharma Data Exchange Hub - Control Plane

**Visual:** Layered architecture

```
┌─────────────────────────────────────────────────────────────┐
│                  SELF-SERVICE PORTAL                         │
│   ┌─────────┐  ┌─────────┐  ┌─────────┐  ┌─────────┐       │
│   │   CMO   │  │Connection│  │  Data   │  │Agreement│       │
│   │Onboard  │  │ Wizard   │  │ Catalog │  │Templates│       │
│   └─────────┘  └─────────┘  └─────────┘  └─────────┘       │
│                    AWS Amplify + Cognito                     │
└─────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────┐
│                  INTEGRATION LAYER                           │
│            ┌─────────────────────────────┐                  │
│            │      API Gateway            │                  │
│            └─────────────────────────────┘                  │
│     ┌──────────┬──────────┬──────────┬──────────┐          │
│     │Pattern 1 │Pattern 2 │Pattern 3 │Pattern 4 │          │
│     │Connector │Connector │Connector │Connector │          │
│     └──────────┴──────────┴──────────┴──────────┘          │
└─────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────┐
│                  GOVERNANCE LAYER                            │
│   ┌─────────┐  ┌─────────┐  ┌─────────┐  ┌─────────┐       │
│   │  Lake   │  │  Glue   │  │  Cloud  │  │  Macie  │       │
│   │Formation│  │ Quality │  │  Trail  │  │(PII Det)│       │
│   └─────────┘  └─────────┘  └─────────┘  └─────────┘       │
└─────────────────────────────────────────────────────────────┘
                              │
                              ▼
┌─────────────────────────────────────────────────────────────┐
│                  UNIFIED DATA LAKE                           │
│        ┌─────────┐  ┌─────────┐  ┌─────────┐               │
│        │ Bronze  │─▶│ Silver  │─▶│  Gold   │               │
│        │  (Raw)  │  │(Curated)│  │(Consume)│               │
│        └─────────┘  └─────────┘  └─────────┘               │
│                    Amazon S3 + Iceberg                       │
└─────────────────────────────────────────────────────────────┘
```

*Speaker Notes:*
Regardless of which pattern a CMO uses, all data flows through a unified control plane. At the top, a self-service portal lets CMOs onboard themselves and select their integration pattern. The integration layer provides consistent APIs across all patterns. The governance layer enforces security, quality, and compliance. At the bottom, all data lands in a unified data lake with bronze, silver, and gold zones. This gives Merck a single, governed view of all CMO data.

---

## Slide 14: Accelerator #1 - Legal Templates

**Title:** Accelerator: Pre-Negotiated Legal Framework

**Visual:** Process comparison

**BEFORE:**
```
┌────────┐   ┌────────┐   ┌────────┐   ┌────────┐
│ Draft  │──▶│ Review │──▶│Negotiate──▶│ Sign   │
│ DPA    │   │ (Legal)│   │ Terms  │   │        │
└────────┘   └────────┘   └────────┘   └────────┘
    │            │            │            │
    └────────────┴────────────┴────────────┘
                 4-8 WEEKS
```

**AFTER:**
```
┌─────────────────────────────────────────────────┐
│         PRE-APPROVED TEMPLATE LIBRARY           │
│  ┌─────────┐  ┌─────────┐  ┌─────────┐         │
│  │   DPA   │  │Security │  │Liability│         │
│  │Template │  │Addendum │  │ Terms   │         │
│  └─────────┘  └─────────┘  └─────────┘         │
└─────────────────────────────────────────────────┘
                      │
                      ▼
              ┌─────────────┐
              │  DocuSign   │
              │  (e-Sign)   │
              └─────────────┘
                      │
                      ▼
               < 1 WEEK
```

**Template Components:**
- Data Processing Agreement (DPA) - GDPR/CCPA compliant
- Security Addendum - AWS shared responsibility model
- Liability & Indemnification - Pre-negotiated terms
- Data Retention & Deletion - Standard policies

*Speaker Notes:*
Legal negotiation is often the longest delay. Our accelerator: pre-negotiate template agreements that CMOs can accept with minimal modification. We work with Merck Legal to create a library of pre-approved templates covering data processing, security, and liability. CMOs review and e-sign through DocuSign integration. This reduces legal cycles from 4-8 weeks to under a week for most CMOs.

---

## Slide 15: Accelerator #2 - Self-Service Onboarding

**Title:** Accelerator: CMO Self-Service Onboarding

**Visual:** Onboarding workflow

```
┌─────────────────────────────────────────────────────────────┐
│                  CMO ONBOARDING JOURNEY                      │
│                                                              │
│  STEP 1           STEP 2           STEP 3           STEP 4  │
│ ┌────────┐      ┌────────┐      ┌────────┐      ┌────────┐ │
│ │Register│      │ Select │      │Configure│     │ Test & │ │
│ │& Verify│─────▶│Pattern │─────▶│Connect │─────▶│Validate│ │
│ └────────┘      └────────┘      └────────┘      └────────┘ │
│     │               │               │               │       │
│     ▼               ▼               ▼               ▼       │
│ ┌────────┐      ┌────────┐      ┌────────┐      ┌────────┐ │
│ │Cognito │      │Pattern │      │CloudFmt│      │Auto    │ │
│ │Identity│      │Wizard  │      │Deploy  │      │Quality │ │
│ │Pool    │      │        │      │        │      │Checks  │ │
│ └────────┘      └────────┘      └────────┘      └────────┘ │
│                                                              │
│  ◀──────────────── 1-3 DAYS ────────────────▶              │
└─────────────────────────────────────────────────────────────┘
```

**Key Capabilities:**
- ✅ CMO self-registration with identity verification
- ✅ Guided pattern selection wizard
- ✅ Automated infrastructure deployment (CloudFormation)
- ✅ Built-in data quality validation
- ✅ No Merck IT bottleneck

*Speaker Notes:*
The second accelerator is self-service onboarding. CMOs don't wait for Merck IT availability. They register through a portal, verify their identity, and use a wizard to select their integration pattern. Behind the scenes, CloudFormation templates automatically deploy the required infrastructure. Built-in data quality checks validate the connection. The entire technical onboarding can happen in 1-3 days without Merck IT involvement.

---

## Slide 16: Accelerator #3 - Pharma Data Standards

**Title:** Accelerator: Pre-Built Pharma Data Models

**Visual:** Schema library

```
┌─────────────────────────────────────────────────────────────┐
│              PHARMA DATA MODEL LIBRARY                       │
│                  (Glue Data Catalog)                         │
│                                                              │
│  ┌─────────────┐  ┌─────────────┐  ┌─────────────┐         │
│  │   BATCH     │  │  EQUIPMENT  │  │   QUALITY   │         │
│  │  RECORDS    │  │    DATA     │  │   EVENTS    │         │
│  │             │  │             │  │             │         │
│  │ • Batch ID  │  │ • Asset ID  │  │ • Deviation │         │
│  │ • Product   │  │ • Location  │  │ • CAPA      │         │
│  │ • Start/End │  │ • Status    │  │ • OOS       │         │
│  │ • Yield     │  │ • Maint.    │  │ • Complaint │         │
│  │ (ISA-88)    │  │             │  │             │         │
│  └─────────────┘  └─────────────┘  └─────────────┘         │
│                                                              │
│  ┌─────────────┐  ┌─────────────┐                          │
│  │ENVIRONMENTAL│  │  MATERIAL   │                          │
│  │ MONITORING  │  │ GENEALOGY   │                          │
│  │             │  │             │                          │
│  │ • Temp/RH   │  │ • Lot trace │                          │
│  │ • Particle  │  │ • CoA data  │                          │
│  │ • Pressure  │  │ • Supplier  │                          │
│  └─────────────┘  └─────────────┘                          │
│                                                              │
│  Format: Apache Iceberg (schema evolution supported)        │
└─────────────────────────────────────────────────────────────┘
```

**Benefits:**
- CMOs map their data to standard schemas
- Merck consumes consistent data regardless of source
- Schema evolution handles changes without breaking pipelines

*Speaker Notes:*
The third accelerator is pre-built pharma data models. Instead of negotiating schemas with each CMO, we define industry-standard models for batch records, equipment data, quality events, and more. CMOs map their data to these standards during onboarding. Merck always receives data in a consistent format. We use Apache Iceberg tables which support schema evolution—so when models need to change, existing pipelines don't break.

---

## Slide 17: Security & Compliance

**Title:** Security & Compliance Architecture

**Visual:** Security layers

```
┌─────────────────────────────────────────────────────────────┐
│                 IDENTITY & ACCESS                            │
│  ┌───────────┐  ┌───────────┐  ┌───────────┐               │
│  │ IAM       │  │   AWS     │  │ Attribute │               │
│  │ Identity  │  │   Orgs    │  │ Based     │               │
│  │ Center    │  │(Multi-Acc)│  │ Access    │               │
│  └───────────┘  └───────────┘  └───────────┘               │
└─────────────────────────────────────────────────────────────┘
┌─────────────────────────────────────────────────────────────┐
│                 DATA PROTECTION                              │
│  ┌───────────┐  ┌───────────┐  ┌───────────┐  ┌──────────┐ │
│  │  AWS KMS  │  │ S3 Object │  │   Macie   │  │  Clean   │ │
│  │ (CMK per  │  │   Lock    │  │ (PII      │  │  Rooms   │ │
│  │   CMO)    │  │  (WORM)   │  │  Detect)  │  │ (Privacy)│ │
│  └───────────┘  └───────────┘  └───────────┘  └──────────┘ │
└─────────────────────────────────────────────────────────────┘
┌─────────────────────────────────────────────────────────────┐
│                 AUDIT & COMPLIANCE                           │
│  ┌───────────┐  ┌───────────┐  ┌───────────┐  ┌──────────┐ │
│  │CloudTrail │  │AWS Config │  │ Security  │  │  Audit   │ │
│  │ (API Log) │  │(Compliance│  │    Hub    │  │ Manager  │ │
│  │           │  │  Rules)   │  │           │  │  (GxP)   │ │
│  └───────────┘  └───────────┘  └───────────┘  └──────────┘ │
└─────────────────────────────────────────────────────────────┘
```

**GxP Compliance (21 CFR Part 11):**
- ✅ Electronic signatures via IAM Identity Center
- ✅ Audit trails via CloudTrail (immutable)
- ✅ Access controls via Lake Formation
- ✅ Data integrity via S3 Object Lock
- ✅ Pre-built controls via AWS Audit Manager

*Speaker Notes:*
Security and compliance are non-negotiable in pharma. Our architecture addresses this at three layers. Identity and access management through IAM Identity Center with attribute-based access control. Data protection through KMS encryption with separate keys per CMO, S3 Object Lock for immutability, and Macie for PII detection. Audit and compliance through CloudTrail logging, Config rules, and Audit Manager with pre-built GxP frameworks. This architecture supports 21 CFR Part 11 requirements out of the box.

---

## Slide 18: Implementation Roadmap

**Title:** Phased Implementation Approach

**Visual:** Timeline with phases

```
┌─────────────────────────────────────────────────────────────────────────────┐
│  PHASE 1              PHASE 2              PHASE 3              PHASE 4     │
│  Foundation           Expansion            Scale                Industry    │
│  (Weeks 1-6)          (Weeks 7-12)         (Weeks 13-20)        (Ongoing)   │
│                                                                              │
│  ┌─────────────┐     ┌─────────────┐     ┌─────────────┐     ┌───────────┐ │
│  │• Core infra │     │• Add Pattern│     │• Add Pattern│     │• Extend to│ │
│  │• Pattern 4  │     │  1 & 3      │     │  2 (Clean   │     │  CROs,    │ │
│  │  (Transfer) │     │• Self-svc   │     │  Rooms)     │     │  Logistics│ │
│  │• 1-2 pilot  │     │  portal     │     │• Cross-CMO  │     │• Publish  │ │
│  │  CMOs       │     │• 5-10 CMOs  │     │  analytics  │     │  ref arch │ │
│  │• Legal      │     │• Data       │     │• Operational│     │• Cont.    │ │
│  │  templates  │     │  quality    │     │  handoff    │     │  improve  │ │
│  └─────────────┘     └─────────────┘     └─────────────┘     └───────────┘ │
│        │                   │                   │                   │        │
│        ▼                   ▼                   ▼                   ▼        │
│   ┌─────────┐         ┌─────────┐         ┌─────────┐         ┌─────────┐  │
│   │2 CMOs   │         │10 CMOs  │         │20+ CMOs │         │Industry │  │
│   │connected│         │connected│         │connected│         │platform │  │
│   └─────────┘         └─────────┘         └─────────┘         └─────────┘  │
└─────────────────────────────────────────────────────────────────────────────┘
```

*Speaker Notes:*
We recommend a phased approach. Phase 1 focuses on foundation—deploying core infrastructure, implementing Pattern 4 as the universal fallback, and onboarding 1-2 pilot CMOs. This validates the approach with minimal risk. Phase 2 expands to add Patterns 1 and 3, builds the self-service portal, and scales to 5-10 CMOs. Phase 3 adds Clean Rooms for privacy-sensitive collaborations and enables cross-CMO analytics. Phase 4 extends the platform to other partners like CROs and logistics providers, positioning this as an industry reference architecture.

---

## Slide 19: Success Metrics

**Title:** Measuring Success

**Visual:** Metrics table with before/after

| Metric | Current State | Target State | Improvement |
|--------|---------------|--------------|-------------|
| Time to first data exchange | 3-6 months | < 2 weeks | **90%+ reduction** |
| Merck onboarding effort | 200+ hours | < 20 hours | **90% reduction** |
| CMO onboarding effort | 100+ hours | < 10 hours | **90% reduction** |
| Integration patterns | Custom each time | 4 standardized | **Repeatable** |
| Legal negotiation time | 4-8 weeks | < 1 week | **75%+ reduction** |
| Data quality issues | Manual discovery | Automated detection | **Proactive** |

**Business Outcomes:**
- 🎯 Faster access to manufacturing insights
- 🎯 Reduced integration costs
- 🎯 Scalable CMO ecosystem
- 🎯 Improved supply chain visibility

*Speaker Notes:*
Here's how we'll measure success. The headline metric is time-to-first-data-exchange—from 3-6 months to under 2 weeks. We'll also track effort reduction on both sides—Merck and CMO. Legal negotiation time should drop from weeks to days. And data quality shifts from reactive manual discovery to proactive automated detection. These metrics directly translate to business outcomes: faster insights, lower costs, and better supply chain visibility.

---

## Slide 20: Investment Summary

**Title:** Investment Overview

**Visual:** Cost breakdown (placeholder - actual numbers TBD)

```
┌─────────────────────────────────────────────────────────────┐
│                 IMPLEMENTATION INVESTMENT                    │
│                                                              │
│  Phase 1 (Foundation)         $XXX,XXX                      │
│  ├─ Infrastructure setup                                     │
│  ├─ Pattern 4 implementation                                 │
│  ├─ Pilot CMO onboarding                                    │
│  └─ Legal template development                               │
│                                                              │
│  Phase 2 (Expansion)          $XXX,XXX                      │
│  ├─ Additional patterns                                      │
│  ├─ Self-service portal                                      │
│  └─ CMO scaling                                              │
│                                                              │
│  Phase 3 (Scale)              $XXX,XXX                      │
│  ├─ Clean Rooms implementation                               │
│  ├─ Advanced analytics                                       │
│  └─ Operational handoff                                      │
│                                                              │
│  ─────────────────────────────────────────                  │
│  TOTAL IMPLEMENTATION         $X.XM                         │
│                                                              │
│  ONGOING (Monthly)            $XX,XXX                       │
│  ├─ AWS infrastructure                                       │
│  ├─ Managed services                                         │
│  └─ Support & maintenance                                    │
└─────────────────────────────────────────────────────────────┘
```

**ROI Considerations:**
- Current cost per CMO integration: $XXX,XXX
- Projected cost per CMO (with platform): $XX,XXX
- Break-even: X CMOs

*Speaker Notes:*
This slide shows the investment overview. I've left the numbers as placeholders—we'll work with you to refine these based on scope and timeline. The key ROI story is that the platform investment pays for itself after just a few CMO integrations. Each CMO you add after that is incremental cost versus the current model of custom integration every time.

---

## Slide 21: Why AWS

**Title:** Why AWS for Pharma Data Exchange

**Visual:** Differentiators

```
┌─────────────────────────────────────────────────────────────┐
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 1. PURPOSE-BUILT SERVICES                            │   │
│  │    • AWS Data Exchange - managed data marketplace    │   │
│  │    • AWS Clean Rooms - privacy-preserving analytics  │   │
│  │    • AWS Transfer Family - managed file transfer     │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 2. LIFE SCIENCES EXPERTISE                           │   │
│  │    • GxP-qualified workloads                         │   │
│  │    • 21 CFR Part 11 compliance frameworks            │   │
│  │    • Pharma customer references                      │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 3. ECOSYSTEM REACH                                   │   │
│  │    • CMOs already on AWS or AWS-compatible           │   │
│  │    • Snowflake partnership (runs on AWS)             │   │
│  │    • ISV integrations                                │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 4. SECURITY & COMPLIANCE                             │   │
│  │    • FedRAMP, HIPAA, SOC certifications              │   │
│  │    • AWS Audit Manager with GxP frameworks           │   │
│  │    • Encryption and access control at every layer    │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
└─────────────────────────────────────────────────────────────┘
```

*Speaker Notes:*
Why AWS for this solution? Four reasons. First, purpose-built services—Data Exchange, Clean Rooms, and Transfer Family are designed exactly for this use case. Second, Life Sciences expertise—we have GxP-qualified workloads and compliance frameworks ready to go. Third, ecosystem reach—many CMOs are already on AWS or use AWS-compatible platforms like Snowflake. Fourth, security and compliance—we have the certifications and tools pharma requires.

---

## Slide 22: Next Steps

**Title:** Recommended Next Steps

**Visual:** Action items with owners

```
┌─────────────────────────────────────────────────────────────┐
│                     NEXT STEPS                               │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 1. VALIDATE CMO PERSONAS                    Week 1-2 │   │
│  │    • Interview 3-5 CMOs on integration preferences   │   │
│  │    • Confirm pattern applicability                   │   │
│  │    Owner: Merck Supply Chain + AWS                   │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 2. LEGAL TEMPLATE DEVELOPMENT               Week 2-4 │   │
│  │    • Engage Merck Legal for template creation        │   │
│  │    • Define acceptable terms for CMO agreements      │   │
│  │    Owner: Merck Legal + Procurement                  │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 3. PILOT CMO SELECTION                      Week 2-3 │   │
│  │    • Identify 2 CMOs (1 cloud-native, 1 legacy)     │   │
│  │    • Secure commitment for pilot participation       │   │
│  │    Owner: Merck Supply Chain                         │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │ 4. AWS ENGAGEMENT                           Week 3-4 │   │
│  │    • Finalize scope and SOW                          │   │
│  │    • Engage AWS ProServe or Partner                  │   │
│  │    Owner: AWS Account Team                           │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
└─────────────────────────────────────────────────────────────┘
```

*Speaker Notes:*
Here are our recommended next steps. First, validate our assumptions by interviewing 3-5 CMOs about their integration preferences. Second, engage Merck Legal to develop the template library—this is critical path. Third, select two pilot CMOs—ideally one cloud-native and one legacy to test different patterns. Fourth, finalize the AWS engagement model. We can have Phase 1 underway within 4-6 weeks of kickoff.

---

## Slide 23: Q&A

**Title:** Questions & Discussion

**Visual:** Clean slide with contact information

```
┌─────────────────────────────────────────────────────────────┐
│                                                              │
│                                                              │
│                    QUESTIONS?                                │
│                                                              │
│                                                              │
│                                                              │
│  ┌─────────────────────────────────────────────────────┐   │
│  │                                                      │   │
│  │  [Your Name]                                         │   │
│  │  Solutions Architect, AWS                            │   │
│  │  [email]                                             │   │
│  │                                                      │   │
│  │  AWS Life Sciences Team                              │   │
│  │  [team email/contact]                                │   │
│  │                                                      │   │
│  └─────────────────────────────────────────────────────┘   │
│                                                              │
│                                                              │
└─────────────────────────────────────────────────────────────┘
```

*Speaker Notes:*
Thank you for your time today. I'm happy to take any questions about the architecture, implementation approach, or next steps. We're excited about the opportunity to help Merck transform CMO data integration from a months-long process to a matter of days.

---

## Slide 24: Appendix - AWS Services Reference

**Title:** Appendix: AWS Services Used

| Service | Purpose |
|---------|---------|
| AWS Data Exchange | Managed data marketplace for CMO data publishing |
| AWS Clean Rooms | Privacy-preserving collaborative analytics |
| AWS Transfer Family | Managed SFTP/FTPS for legacy CMO integration |
| Amazon S3 | Data lake storage (Bronze/Silver/Gold zones) |
| AWS Glue | ETL, data catalog, data quality |
| AWS Lake Formation | Fine-grained access control and governance |
| Amazon Athena | Serverless SQL queries |
| Amazon Redshift | Data warehouse for analytics |
| AWS Step Functions | Workflow orchestration |
| Amazon EventBridge | Event-driven automation |
| AWS KMS | Encryption key management |
| Amazon Macie | Sensitive data discovery |
| AWS CloudTrail | API audit logging |
| AWS Config | Compliance monitoring |
| AWS Audit Manager | GxP compliance frameworks |
| Amazon Cognito | CMO identity management |
| AWS Amplify | Self-service portal frontend |
| Amazon API Gateway | API management |
| AWS Direct Connect | Secure network connectivity |

---

## Slide 25: Appendix - Pattern Comparison

**Title:** Appendix: Detailed Pattern Comparison

| Criteria | Pattern 1: Data Exchange | Pattern 2: Clean Rooms | Pattern 3: Snowflake | Pattern 4: Transfer |
|----------|-------------------------|------------------------|---------------------|---------------------|
| CMO Cloud Requirement | AWS Account | AWS Account | Snowflake | None |
| Data Movement | Full copy to Merck | No movement | Zero-copy or S3 | File transfer |
| Privacy Level | Standard | Maximum | Standard | Standard |
| Real-time Capability | Near real-time | Query-based | Near real-time | Batch |
| CMO Effort | Medium | Medium | Low | Low |
| Merck Effort | Low | Medium | Low | Medium |
| Best For | Cloud-native CMOs | Privacy-sensitive | Snowflake users | Legacy systems |
| Time to Value | 1-2 weeks | 2-3 weeks | 1-2 weeks | 2-4 weeks |

---

This completes the presentation structure. Would you like me to:

1. **Expand any specific slide** with more detail?
2. **Create additional appendix slides** (e.g., detailed architecture for each pattern)?
3. **Develop speaker notes** in more depth for specific slides?
4. **Add a competitive comparison** slide (vs. other approaches)?